Healthcare (Prescription Drugs)

introduced · Ohio · House Jul 1, 2026

HB 972: Prohibit certain health plan issuer pharmacy restrictions

To enact section 3902.78 of the Revised Code to prohibit a health plan issuer from imposing restrictions on pharmacy services that increase transparency and prescription drug access for patients.

Topics ✓ HealthcareSupports HealthcareBill prohibits restrictions on pharmacy services to increase transparency and prescription drug access, directly supporting patient healthcare access.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

in committee · Ohio · House May 20, 2026

HB 892: Enact the Ohio-Made Prescription Drug Act

To enact section 125.62 of the Revised Code to establish the Ohio-Made Medicine Manufacturing Program and to name this act the Ohio-Made Prescription Drug Act.

Topics ✓ HealthcareSupports HealthcareBill establishes a manufacturing program to increase domestic production of prescription drugs, aiming to improve access and affordability.85% confidence

Sub-Topics Prescription Drugs

Track

in committee · Ohio · House May 20, 2026

HB 890: Enact Prescription Relief, Inflation Cost Elimination (PRICE) Act

To enact sections 3901.85, 3901.851, 3901.852, 3901.853, 3901.854, 3901.855, 3901.856, 3901.857, and 3901.858 and to repeal section 125.95 of the Revised Code to establish the Prescription Drug Affordability Board and Prescription Drug Affordability Stakeholder Council, to authorize the establishment of upper payment limits on certain prescription drug products, to repeal the law establishing the Prescription Drug Transparency and Affordability Advisory Council, and to name this act the Prescription Relief and Inflation Cost Elimination or P.R.I.C.E. Act.

Topics ✓ HealthcareSupports HealthcareBill aims to lower prescription drug costs and establish an affordability board, directly improving patient access and reducing financial barriers to healthcare.85% confidence

Sub-Topics Prescription Drugs

Track

in committee · Ohio · House Feb 18, 2026

HB 699: Require prescription drug coverage by health plan issuers

HB 699 requires health insurance plans sold in Ohio to cover all prescription drugs approved by the U.S. Food and Drug Administration (FDA) for a patient's specific condition, provided the drug is recognized by an approved medical reference or peer-reviewed literature. It mandates coverage for all medically necessary services related to administering the drug, prohibits denials based solely on a drug's legal status, and exempts experimental drugs not FDA-approved for the condition or drugs contraindicated by the FDA. This directly affects health insurance issuers and policyholders by ensuring access to covered prescription drugs for diagnosed conditions. The bill does not require coverage for drugs not approved by the FDA or those deemed unsafe for the condition.

Topics ✓ HealthcareSupports HealthcareMandates coverage for all FDA-approved prescription drugs and prohibits denials based on drug legality, expanding patient access and protecting rights to necessary medications.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

in committee · Ohio · House Feb 18, 2026

HB 682: Prohibit certain insurance practices

To enact section 3902.65 of the Revised Code to prohibit certain insurance practices related to physician-administered drugs for patients with chronic, complex, rare, or life-threatening medical conditions.

Topics ✓ HealthcareSupports HealthcareBill prohibits insurance restrictions on physician-administered drugs for critical conditions, improving patient access and protecting coverage rights. Directly aligns with healthcare support indicators.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · Ohio · House Feb 4, 2026

HB 629: Enact the Pharmacist Prescribing Authority Act

To amend sections 339.78, 339.81, 1751.91, 3923.89, 4729.01, and 4729.39 and to enact sections 4729.21 and 4729.211 of the Revised Code to authorize pharmacists to treat minor health conditions and to name this act the Pharmacist Prescribing Authority Act.

Topics ✓ HealthcareSupports HealthcareAuthorizes pharmacists to treat minor conditions, expanding patient access to healthcare services without requiring physician visits.95% confidence

Sub-Topics Prescription Drugs

Track

passed · Ohio · Senate Jun 16, 2026

SB 160: Regards prescription drugs and medication switching

SB 160 prohibits health insurance plans from making certain changes to drug coverage during a plan year, such as increasing patient costs, moving drugs to more restrictive tiers, or removing drugs from formularies (except for specific safety or manufacturer discontinuation reasons). It directly affects health insurance issuers and plan members by limiting how insurers can adjust coverage for prescription drugs. Key provisions include allowing generic substitution when available, preventing prior authorization for covered drugs, and exempting plans from restrictions if a drug’s cost rises more than 5% plus inflation. The bill aims to stabilize drug access for patients while permitting standard practices like formulary additions and generic substitutions.

Topics ✓ HealthcareSupports HealthcareSB 160 protects patient access to prescription drugs and prevents increased costs by limiting insurers' ability to change drug coverage during a plan year.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

in committee · Ohio · House Sep 15, 2025

HB 374: Regards prescription drug readers for visually impaired patients

To amend section 5167.12 and to enact sections 3902.65, 4729.362, and 5164.093 of the Revised Code regarding prescription drug readers for visually impaired patients.

Topics ✓ HealthcareSupports HealthcareBill enacts provisions for prescription drug readers for visually impaired patients, directly improving patient access to critical medication information and safety.95% confidence ✓ TechnologySupports TechnologyThe bill regards prescription drug readers for visually impaired patients, which are assistive technologies promoting digital equity and access.85% confidence

Sub-Topics Prescription Drugs

Track

signed · Ohio · House Jun 30, 2026

HB 229: Establish licensing process, contract requirements for PBMs

To amend section 3959.01 and to enact sections 3957.01, 3957.02, 3957.03, 3957.04, 3957.05, 3957.06, 3957.07, 3957.08, 3957.09, 3957.10, 3957.11, 3957.12, 3957.13, 3957.14, 3957.15, 3957.16, 3957.17, and 3957.99 of the Revised Code to establish a stand-alone licensing process and new contractual requirements for pharmacy benefit managers.

Topics ✓ HealthcareSupports HealthcareThe bill establishes licensing and contract requirements for PBMs, which are key players in healthcare. This regulation aims to strengthen oversight and improve the functioning of the healthcare system.80% confidence

Sub-Topics Prescription Drugs

in committee · Ohio · House May 14, 2025

HB 263: Cap cost sharing for prescription insulin drugs, diabetes devices

HB 263 proposes to limit the out-of-pocket costs for individuals needing essential diabetes treatments. The bill specifically aims to cap cost-sharing for prescription insulin drugs, diabetes devices, and devices used to treat diabetic ketoacidosis. If enacted, it would establish a new section in the Revised Code to enforce these caps, reducing the financial burden on patients who rely on these medical necessities.

Topics ✓ HealthcareSupports HealthcareHB 263 caps out-of-pocket costs for essential diabetes treatments, directly improving patient access to health services and reducing financial burdens.95% confidence ✓ Labor & EmploymentSupports Labor & EmploymentReduces significant healthcare costs for individuals, including workers, indirectly supporting their financial stability and ability to maintain employment.60% confidence

Sub-Topics Prescription Drugs

Track